Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 30 min 29 sec ago

EnteroMedics Announces Closing of $6.25 Million Third Tranche of Previously-Announced Convertible Notes Offering

Tue, 05/03/2016 - 13:38
ST. PAUL, Minn., May 3, 2016 -- (Healthcare Sales & Marketing Network) -- EnteroMedics Inc. (ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced ...
Devices, Venture Capital
EnteroMedics, neuroblocking, vBloc

Exact Sciences Completes 40,000 Cologuard Tests during First Quarter 2016

Tue, 05/03/2016 - 13:28
Revenue increases 244 percent year-over-year to $14.8 million; Commercial strategy strengthened in 2016 with television advertising campaign MADISON, Wis., May 3, 2016 -- (Healthcare Sales & Marketing Network) -- Exact Sciences Corp. (EXAS) today annou...
Diagnostics, Oncology
EXACT SCIENCES, Cologuard, colorectal cancer

Perrigo Announces FDA Approval and Launch of the Generic Version of BenzaClin(R) Pump Topical Gel

Mon, 05/02/2016 - 19:53
DUBLIN, May 2, 2016 -- (Healthcare Sales & Marketing Network) -- Perrigo Company plc (NYSE: PRGO; TASE) today announced it has received final U.S. Food and Drug Administration ("FDA") approval for the generic version of Valeant Pharmaceutical In...
Biopharmaceuticals, Generics, FDA, Product Launch
Perrigo, BenzaClin, Valeant Pharmaceutical

Endo Announces U.S. District Court Ruling Upholding OPANA(R) ER Intellectual Property

Mon, 05/02/2016 - 19:49
DUBLIN, May 2, 2016 -- (Healthcare Sales & Marketing Network) -- Endo International plc (ENDP) (ENL.TO) today announced that the U.S. District Court for the Southern District of New York has issued an order upholding its August 2015 ruling in Endo's favor...
Biopharmaceuticals, Generics, Litigation
Endo International, OPANA

EndoChoice(R) Announces William Enquist as New Chairman of the Board

Mon, 05/02/2016 - 19:45
ALPHARETTA, Ga., May 2, 2016 -- (Healthcare Sales & Marketing Network) -- EndoChoice Holdings, Inc. (GI) announced today that existing Board member William (Bill) Enquist has been elevated to the position of Chairman of the Board of Directors. Scott Huenn...
Devices, Gastroenterology, Oncology, Personnel
EndoChoice, endoscopy, colon cancer

Graybug Vision Announces $44.5 Million Series B Financing

Mon, 05/02/2016 - 19:43
Funding Will Support Clinical Development Activities REDWOOD CITY, CA--(Healthcare Sales & Marketing Network) - Graybug Vision, a venture-stage pharmaceutical company committed to developing potentially transformative therapies for ocular diseases inclu...
Biopharmaceuticals, Ophthalmology, Venture Capital
Graybug Vision, macular degeneration

Allergan Receives FDA Approval and Launches First Generic Version of CRESTOR(R) (rosuvastatin)

Mon, 05/02/2016 - 19:40
DUBLIN, May 2, 2016 -- (Healthcare Sales & Marketing Network) -- Allergan plc (AGN), a leading global pharmaceutical company, today confirmed that it has received final approval from the U.S. Food and Drug Administration (FDA) on its Abbreviated New Drug ...
Biopharmaceuticals, Generics, FDA, Product Launch
Allergan, CRESTOR, rosuvastatin, AstraZeneca

Enhanced Cystoscopy including Blue Light Cystoscopy with Cysview(R)/Hexvix(R) is Recommended in the New AUA/SUO Bladder Cancer Guideline

Mon, 05/02/2016 - 13:50
PRINCETON, N.J., May 2, 2016 -- (Healthcare Sales & Marketing Network) -- Photocure Inc. announced today the American Urological Association (AUA) and the Society of Urological Oncology (SUO) have included enhanced cystoscopy in the 2016 Guidelines for th...
Biopharmaceuticals, Diagnostics, Urology, Oncology
Photocure, cystoscopy, bladder cancer, Cysview, Hexvix

EnteroMedics Announces Exclusive Federal Government Business Channel Sales Agreement with Academy Medical to Provide vBloc(R) Neurometabolic Therapy to US Department of Veterans Affairs Medical Facilities

Mon, 05/02/2016 - 13:39
ST. PAUL, Minn., May 2, 2016 -- (Healthcare Sales & Marketing Network) -- EnteroMedics Inc. (ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced ...
Devices, Distribution
EnteroMedics, neuroblocking, vBloc therapy

Corsens Medical Ltd., Announces Filing of a 510(k) Pre-Marketing Notification with the US Food and Drug Administration for the Corsens Cardiac Monitor

Mon, 05/02/2016 - 13:30
The Cardiac Monitor is intended to detect heart contractility parameters required for continuous heart function monitoring TEL AVIV, Israel--(Healthcare Sales & Marketing Network)--Corsens Medical Ltd., today announced that it has successfully completed...
Devices, Cardiology, Monitoring, FDA
Corsens Medical, Corsens Cardiac Monitor, cardiac contractility

Accuray Signs Long-Term Strategic Development and Supply Agreement with medPhoton for Volumetric Image Guidance Solutions for the CyberKnife(R) System

Mon, 05/02/2016 - 13:21
Collaboration Designed to Expand Clinical Versatility of the CyberKnife® System with Addition of medPhoton Novel Imaging Solution SUNNYVALE, Calif., May 1, 2016 -- (Healthcare Sales & Marketing Network) -- Accuray Incorporated (ARAY) announced toda...
Devices, Oncology
Accuray, medPhoton, ImagingRing, CyberKnife, radiosurgery

Boston Scientific Receives U.S. FDA Approval For ImageReady(TM) MR-Conditional Pacing System

Fri, 04/29/2016 - 18:44
FDA approval includes ACCOLADE™ MRI and ESSENTIO™ MRI pacemakers and INGEVITY™ MRI pacing leads MARLBOROUGH, Mass., April 25, 2016 -- (Healthcare Sales & Marketing Network) -- Boston Scientific (NYSE: BSX) has received U.S. Food and Drug Administration...
Devices, Cardiology, Radiology, FDA
Boston Scientific, ImageReady, pacemaker, magnetic resonance imaging

Allergan Receives CHMP Positive Opinion For ENZEPI(R) (Pancrelipase) For Patients With Exocrine Pancreatic Insufficiency (EPI)

Fri, 04/29/2016 - 18:32
Significant step to bringing this effective therapy to EPI patients in the 28 countries of the EU Specifically formulated to meet the CHMP guidelines on lipase enzyme activity ensuring no-overfill leading to accuracy and consistency of dosing Further...
Biopharmaceuticals, Regulatory
Allergan, ENZEPI, Pancrelipase, Exocrine Pancreatic Insufficiency

Stryker’s Spine Division Debuts 3D-Printed Tritanium(R) Posterior Lumbar Cage at AANS Meeting

Fri, 04/29/2016 - 18:18
Proprietary Tritanium Technology, in Spinal Applications, Is Designed for Bone In-Growth & Enhanced Biological Fixation ALLENDALE, N.J.--(Healthcare Sales & Marketing Network)--Stryker’s Spine division will introduce the Tritanium Posterior Lumbar (PL) ...
Devices, Orthopaedic, Neurosurgery, Product Launch
Stryker, Tritanium, Lumbar Cage, spinal fusion

Wenzel Spine Announces Commercial Launch of the VariLift(R)-LX

Fri, 04/29/2016 - 13:47
Company Continues Expansion of Expandable Stand-Alone Portfolio AUSTIN, Texas--(Healthcare Sales & Marketing Network)--Wenzel Spine, Inc., a pioneer medical device company focused on providing minimally invasive, expandable stand-alone alternatives to t...
Devices, Orthopaedic, Neurosurgery, Product Launch
Wenzel Spine, VariLift-LX, interbody fusion device, spine surgery

Elekta's Latest Monaco Release Features Up to Four Times Faster Calculation Speed for Reduced Radiotherapy Planning Times

Fri, 04/29/2016 - 13:20
Monaco 5.11 makes debut at ESTRO 35 in Italy TURIN, Italy, April 29, 2016 -- (Healthcare Sales & Marketing Network) -- Elekta is pleased to announce that Monaco® version 5.11, the latest update to its industry-leading treatment planning software, i...
Devices, Oncology, Product Launch
Elekta, treatment planning, Monaco, VMAT, radiosurgery, radiotherapy

Pliant Therapeutics Expands Leadership Team

Thu, 04/28/2016 - 14:30
Appoints Three Seasoned Executives to Advance Therapies to Prevent or Reverse Fibrotic Diseases REDWOOD CITY, Calif.--(Healthcare Sales & Marketing Network)--Pliant Therapeutics, Inc., a company focused on discovering, developing and commercializing bre...
Biopharmaceuticals, Personnel
Pliant Therapeutics, fibrotic disease

Varian Gives European Clinicians First Glimpse of Next Big Advance in Radiotherapy at ESTRO 35

Thu, 04/28/2016 - 14:23
TURIN, Italy, April 28, 2016 -- (Healthcare Sales & Marketing Network) -- Varian Medical Systems will demonstrate its full range of radiotherapy delivery systems at the 35th ESTRO (European Society for Radiotherapy and Oncology) meeting, taking place here...
Devices, Oncology
Varian Medical Systems, radiotherapy, radiosurgery, High Definition Radiotherapy

Abbott to Acquire St. Jude Medical

Thu, 04/28/2016 - 13:56
COMBINATION WILL CREATE A PREMIER MEDICAL DEVICE LEADER AND STRENGTHEN ABBOTT'S LONG-TERM GROWTH POTENTIAL Acquisition will enhance Abbott's global scale and capabilities and will further diversify its portfolio of best-in-class products and revenue sou...
Devices, Cardiology, Mergers & Acquisitions
Abbott, St. Jude Medical

Study Shows Minute Ventilation Preferred Over End-Tidal CO(2) In Monitoring For Life-Threatening Opioid Induced Respiratory Depression

Thu, 04/28/2016 - 13:43
WALTHAM, Mass., April 28, 2016 -- (Healthcare Sales & Marketing Network) -- Respiratory Motion, Inc. – Research presented at The Deutsche Anesthesia Congress (DAC) Shows Minute Ventilation Monitoring may be preferable to indirect measurement using EtCO2, ...
Devices, Monitoring
Respiratory Motion Inc, Minute Ventilation Monitoring

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong